CKS2 Promotes the Growth in Non-Small-Cell Lung Cancer by Downregulating Cyclin-Dependent Kinase Inhibitor

Conclusions: Our study suggests that CKS2 could be a biomarker in the progression and prognosis of NSCLC.Pathobiology
Source: Pathobiology - Category: Pathology Source Type: research